SurgicEye is a complimentary technology in which EBG has exclusive licensor in both Canada and China. SurgicEye's high-quality imaging solutions and reconstruction capabilities enable 3D SPECT imaging and navigation during intra-operative lympho-scintigraphy and lesion localization procedures. SurgicEye’s cornerstone product, declipseSPECT, provides intraoperative 3D image visualization and navigation for gamma probes during radio-guided surgery to resect labeled structures like tumors, metastases and sentinel lymph nodes. Even small and deeper-seated lesions can be instantly localized and precisely differentiated. The solution offers an instrument to safely perform minimally invasive and complete tumor surgery.
Enigma Biomedical Group has licensed from Dilon, a gamma camera technology that is designed specifically for women and breast imaging. Combined with a radio labelled isotope, Sestamibi, this procedure can help detect tumors in women with both normal and dense breast tissue in a more discreet and physically comfortable environment than current technology. Dilon has been available in the US for several years and has received Canadian approval in June of 2012.